Login
$BL
$34.18 -$0.62 (1.78%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
ASSETS
Current assets:
Cash and cash equivalents
Marketable securities (amortized cost of $285,087 and $387,936 at June 30, 2026 and December 31, 2025, respectively)
Accounts receivable, net of allowances of $2,734 and $2,970 at June 30, 2026 and December 31, 2025, respectively
Prepaid expenses and other current assets
Total current assets
Capitalized software development costs, net
Property and equipment, net
Intangible assets, net
Goodwill
Operating lease right-of-use assets
Deferred tax assets, net
Other assets
Total assets
LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Deferred revenue, current
Finance lease liabilities, current
Operating lease liabilities, current
Convertible senior notes, net, current
Contingent consideration, current
Total current liabilities
Finance lease liabilities, noncurrent
Operating lease liabilities, noncurrent
Convertible senior notes, net, noncurrent
Contingent consideration, noncurrent
Deferred tax liabilities, net
Deferred revenue, noncurrent
Other long-term liabilities
Total liabilities
Redeemable non-controlling interest (Note 4)
Stockholders' equity:
Common stock, $0.01 par value, 500,000,000 shares authorized, 58,376,978 and 59,880,563 issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders' equity
Total liabilities, redeemable non-controlling interest, and stockholders' equity
Amortized cost

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support